Comparison of Familial Clustering of Anogenital and Skin Cancers Between In Situ and Invasive Types.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 11 2019
Historique:
received: 20 11 2018
accepted: 23 07 2019
entrez: 8 11 2019
pubmed: 7 11 2019
medline: 3 11 2020
Statut: epublish

Résumé

Literature on familial risk of carcinomas in situ (CISs) is limited because many cancer registries do not collect information on CIS. In Sweden CISs are collected, and we used these data to analyze familial relative risks (RRs) for concordant (CIS-CIS) types of anogenital (cervical, other female and male genital and anal) and skin squamous cell CIS; additionally RRs were assessed between CIS types and between CIS and invasive forms. RRs were calculated for the offspring generations when family members were diagnosed CIS. Case numbers for CIS ranged from 330 in anal to 177,285 in cervical CIS. Significant concordant CIS-CIS RRs were 2.74 for female genital, 1.77 for cervical and 2.29 for SCC skin CISs. The CIS forms associated also with each other, except for cervical and skin CIS types. RRs for concordant CIS-invasive cancer associations were lower than CIS-CIS associations. Cervical CIS associated with non-Hodgkin CIS which may suggest immune dysfunction as a contributing factors. The results for anogenital CIS types suggest that life style related human papilloma virus infections contributed to the observed familial associations. Lower risks for CIS-invasive cancer than CIS-CIS suggest that CIS and invasive cancers share only partially risk factors that underlie familial clustering.

Identifiants

pubmed: 31695117
doi: 10.1038/s41598-019-51651-6
pii: 10.1038/s41598-019-51651-6
pmc: PMC6834624
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16151

Références

J Invest Dermatol. 2010 May;130(5):1323-8
pubmed: 20090766
J Invest Dermatol. 2009 Sep;129(9):2142-7
pubmed: 19242514
Eur J Cancer Prev. 2002 Oct;11(5):433-8
pubmed: 12394240
CA Cancer J Clin. 2016 Sep;66(5):408-36
pubmed: 27270763
Int J Cancer. 2010 May 15;126(10):2259-67
pubmed: 19642094
Nat Rev Nephrol. 2010 Sep;6(9):511-9
pubmed: 20736984
J Natl Cancer Inst. 2005 Nov 2;97(21):1575-9
pubmed: 16264177
Ann Glob Health. 2014 Sep-Oct;80(5):384-92
pubmed: 25512154
Int J Cancer. 2012 Nov 1;131(9):2085-93
pubmed: 22307919
Int J Cancer. 2008 Apr 15;122(8):1873-8
pubmed: 18074353
J Pediatr. 2012 May;160(5):837-43
pubmed: 22137368
Int J Cancer. 2017 Mar 1;140(5):1091-1101
pubmed: 27870055
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441
pubmed: 23189750
Int J Cancer. 1995 Jan 17;60(2):183-9
pubmed: 7829213
Kidney Int. 2007 Jun;71(12):1271-8
pubmed: 17332737
Am J Transplant. 2018 May;18(5):1220-1230
pubmed: 29024374
Acta Oncol. 2018 Apr;57(4):440-455
pubmed: 29226751
Eur J Cancer. 2014 Oct;50(15):2659-67
pubmed: 25103454
Virology. 2009 Sep 15;392(1):1-10
pubmed: 19720205
Sci Rep. 2017 Aug 14;7(1):8073
pubmed: 28808281
APMIS. 2010 Jun;118(6-7):494-509
pubmed: 20553530

Auteurs

Luyao Zhang (L)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.
Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.

Otto Hemminki (O)

Department of Urology, Helsinki University Hospital, Helsinki, Finland.
Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Guoqiao Zheng (G)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.
Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.

Asta Försti (A)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.
Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden.

Kristina Sundquist (K)

Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden.
Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.
Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan.

Jan Sundquist (J)

Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden.
Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.
Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan.

Kari Hemminki (K)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. k.hemminki@dkfz.de.
Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden. k.hemminki@dkfz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH